{"paper_id":"5f4d0089-c163-4580-b08c-08ed8f8284d7","body_text":"Abstract\nBoth menstrual pain and heavy menstrual bleeding no longer represent the debilitating threat they once posed. Inexpensive, safe, effective non-prescription therapy available without medical consultation means that dysmenorrhea is no longer the source of disability it once was. When this is not enough, prescription interventions offer exceptional efficacy. When heavy menstrual bleeding is experienced, the placement of a hormone-releasing intrauterine device (LNG-IUS) offers efficacy for 5 or more years with no further actions by the user. Normality can be restored, worry relieved, and function maintained.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nDe Sanctis V, Soliman A, Bernasconi S, et al. Primary dysmenorrhea in adolescents: prevalence, impact and recent knowledge. Pediatr Endocrinol Rev. 2015;13(2):512–20.\nDerry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281.\nLee B, Hong SH, Kim K, et al. Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, single-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;194:58–63.\nIgwea SE, Tabansi-Ochuogu CS, Abaraogu UO. TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea: a systematic review. Complement Ther Clin Pract. 2016;24:86–91.\nYiu KW, Chan SS, Chung TK. Mothers’ attitude to the use of a combined oral contraceptive pill by their daughters for menstrual disorders or contraception. Hong Kong Med J. 2017;23(2):150–7.\nHarel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D. Adolescents’ experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol. 2005;18(2):85–90.\nLing FW, For the Pelvic Pain Study Group. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol. 1999;93:51–8.\nAmerican College of Obstetricians and Gynecologists. Management of endometriosis. Practice Bulletin No. 113. Obstet Gynecol. 2010;116:223–36.\nSulak PJ, Cressman BE, Waldrop E, Holleman S, Kuehl TJ. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997;89(2):179–83.\nWilkinson JP, Kadir RA. Management of abnormal uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. 2010;23:S22–30.\nLichten EM, Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reprod Med. 1987;32:37–41.\nVercellini P, Aimi G, Busacca M, et al. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril. 2003;80(2):310–9.\nProctor ML, Latthe PM, Farquhar CM, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2005;(4):CD001896.\nLatthe PM, Proctor ML, Farquhar CM, Johnson N, Khan KS. Surgical interruption of pelvic nerve pathways in dysmenorrhea: a systematic review of effectiveness. Acta Obstet Gynecol Scand. 2007;86(1):4–15.\nWebster JC. Diseases of women: a text-book for students and practitioners. Edinburgh & London: Young J. Pentland; 1898. p. 57. Fig. 29\nYen YK, Liu WM, Yuan CC, Ng HT. Addition of laparoscopic uterine nerve ablation to laparoscopic bipolar coagulation of uterine vessels for women with uterine myomas and dysmenorrhea. J Am Assoc Gynecol Laparosc. 2001;8(4):573–8.\nJuang CM, Chou P, Yen MS, et al. Laparoscopic uterosacral nerve ablation with and without presacral neurectomy in the treatment of primary dysmenorrhea: a prospective efficacy analysis. J Reprod Med. 2007;52:591–6.\nChen FP, Chang SD, Chu KK, Soong YK. Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J Reprod Med. 1996;41:463–6.\nPapasakelariou C. Long-term results of laparoscopic uterosacral nerve ablation. Gynaecol Endosc. 1996;5:177–9.\nMoawad NS, Santamaria E, Johnson M, Shuster J. Cost-effectiveness of office hysteroscopy for abnormal uterine bleeding. JSLS. 2014;18(3.) pii: e2014.00393\nDi Spiezio SA, Spinelli M, Zizolfi B, Nappi C. Ambulatory management of heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):35–43.\nDI Spiezio Sardo A, Ceci O, Zizolfi B, Nappi C, Bettocchi S. Office myomectomy. Minerva Ginecol. 2016;68(3):321–7.\nWortman M. “See-and-treat” hysteroscopy in the management of endometrial polyps. Surg Technol Int. 2016;28:177–84.\nKeyhan S, Munro MG. Office diagnostic and operative hysteroscopy using local anesthesia only: an analysis of patient reported pain and other procedural outcomes. J Minim Invasive Gynecol. 2014;21(5):791–8.\nCooper NA, Middleton L, Smith P, et al. OPT trial collaborative group. A patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding. Gynecol Surg. 2016;13(4):313–22.\nDuplay S, Clado S. Traité d'Hystéroscopie, Instrumentation, Technique Opératoire, Études Cliniques. Rennes: Fr. Simon, Succ De A Le Roy, Impriveur Dreveté; 1898. p. 60.\nDavies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017;151(Suppl 1):S70–7.\nFergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;(11):CD000329.\nMarjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2016;(1):CD003855.\nLethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid. 2011;2011. pii: 0814\nScarperi S, Pontrelli G, Campana C, et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis. JSLS. 2015;19(4.) pii: e2015.00071\nAdditional Resources\nAmerican College of Obstetricians and Gynecologists. Endometrial ablation. ACOG Practice Bulletin No. 81. Obstet Gynecol. 2007;109:1233–48.\nAmerican College of Obstetricians and Gynecologists. Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin No. 96. Obstet Gynecol. 2008;112:201–7.\nCentini G, Troia L, Lazzeri L, Petraglia F, Luisi S. Modern operative hysteroscopy. Minerva Ginecol. 2016;68(2):126–32.\nDavies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017;151(Suppl 1):S70–7.\nGimpelson RJ. Office hysteroscopy. Clin Obstet Gynecol. 1992;35(2):270–81.\nHeikinheimo O, Fraser I. The current status of hormonal therapies for heavy menstrual bleeding. Best Pract Res Clin Obstet Gynaecol. 2017;40:111–20.\nKwok A, Lam A, Ford R. Laparoscopic presacral neurectomy: a review. Obstet Gynecol Surv. 2001;56(2):99–104.\nKumar V, Chodankar R, Gupta JK. Endometrial ablation for heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):45–52.\nMaybin JA, Critchley HO. Medical management of heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):27–34.\nRay S, Ray A. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders. Cochrane Database Syst Rev. 2016;(11):CD010338.\nAuthor information\nAuthors and Affiliations\nRights and permissions\nCopyright information\n© 2018 Springer International Publishing AG\nAbout this chapter\nCite this chapter\nSmith, R.P. (2018). Options for When Simple Managements Are Not Enough. In: Dysmenorrhea and Menorrhagia. Springer, Cham. https://doi.org/10.1007/978-3-319-71964-1_11\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-71964-1_11\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-71963-4\nOnline ISBN: 978-3-319-71964-1\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}